Shareholders' equity · 2017–2025
Amneal Pharmaceuticals shareholders' equity
−$70.8M+$38.5M · FY2025
Amneal Pharmaceuticals (AMRX) reported −$70.8M in shareholders' equity for fiscal 2025, +$38.5M from the year before.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | −$70.8M | +$38.5M | Open → |
| FY20242024-12-31 | −$109M | −$129M | Open → |
| FY20232023-12-31 | $19.8M | −93.4% | Open → |
| FY20222022-12-31 | $298M | −17.2% | Open → |
| FY20212021-12-31 | $360M | +18.8% | Open → |
| FY20202020-12-31 | $303M | +30.7% | Open → |
| FY20192019-12-31 | $232M | −54.0% | Open → |
| FY20182018-12-31 | $505M | +$505M | Open → |
| FY20172017-12-31 | $0 | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Amneal Pharmaceuticals shareholders' equity |url=https://companiesranked.com/en/company/amneal-pharmaceuticals/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Amneal Pharmaceuticals shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/amneal-pharmaceuticals/shareholders-equityBibTeX
@misc{companiesranked-en-company-amneal-pharmaceuticals-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Amneal Pharmaceuticals shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/amneal-pharmaceuticals/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001723128-26-000031 · August 6, 2026
{{cite web |title=Amneal Pharmaceuticals shareholders' equity — 10-Q (0001723128-26-000031) |url=https://www.sec.gov/Archives/edgar/data/1723128/000172312826000031/amrx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.